Related Experiment Video
Updated: Aug 17, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Statins and transcriptional regulation: the FXR connection
Ioannis Habeos1, Panos G Ziros, Agathoklis Psyrogiannis
1Department of Biochemistry, School of Medicine, University of Patras, 26110 Patras, Greece.
Abstract:
Farnesoid X receptor (FXR) is a nuclear receptor involved in lipoprotein as well as glucose metabolism. Statins are widely used hypolipidemic agents with many pleiotropic actions. It is known that statins affect other nuclear hormone receptors, but no reports are available on the effect of these drugs on FXR. Employing an animal model (Syrian hamsters), we hereby present evidence to demonstrate that Simvastatin, a broadly prescribed statin, decreases the expression of FXR at both the RNA and protein levels and down-regulates its DNA-binding activity. This novel property may have important implications on the mode statins influence on lipoprotein and carbohydrate homeostasis in the organism.
Insights
Simvastatin, a common statin, was found to reduce the expression and DNA-binding activity of Farnesoid X receptor (FXR), a key regulator of lipid and glucose metabolism.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Farnesoid X receptor (FXR) plays a crucial role in regulating lipoprotein and glucose metabolism.
- Statins are widely prescribed hypolipidemic drugs with diverse effects on nuclear hormone receptors.
- The impact of statins on FXR has not been previously reported.
Purpose of the Study:
- To investigate the effect of Simvastatin on FXR expression and activity.
- To explore potential implications for lipid and carbohydrate homeostasis.
Main Methods:
- Utilized a Syrian hamster animal model.
- Assessed FXR expression at both RNA and protein levels.
- Measured FXR DNA-binding activity.
Main Results:
- Simvastatin treatment led to a decrease in FXR expression at the RNA level.
- Simvastatin also reduced FXR protein levels.
- The DNA-binding activity of FXR was down-regulated by Simvastatin.
Conclusions:
- Simvastatin demonstrably decreases FXR expression and DNA-binding activity.
- This finding suggests a novel mechanism by which statins influence metabolic homeostasis.
- Further research is warranted to elucidate the full implications for lipoprotein and carbohydrate metabolism.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Co-activators and Co-repressors
Co-activators and Co-repressors
Master Transcription Regulators
Master Transcription Regulators
Transcriptional Regulation: Riboswitches